Glycosylation of Recombinant Anticancer Therapeutics in Different Expression Systems with Emerging Technologies
نویسندگان
چکیده
منابع مشابه
Novel therapeutics and emerging technologies in head and neck cancer
Head and neck cancer remains the fifth most common cancer worldwide. With the emergence of the human papillomavirus (HPV) epidemic, the incidence of this malignancy is increasing at an alarming rate and the public health implications are far-reaching. Fortunately, the scientific community has been accelerating its rate of discovery as well. This special issue of the “World Journal of Otolaryngo...
متن کاملEmerging technologies: systems biology.
The field of systems biology is based on the paradigm that the whole is greater than the sum of the parts. Through a combination of high-throughput experiments analyzing "-omic" scale phenomenon and the development of new computational techniques and algorithms, it is now feasible to study biological systems in a way that was previously not possible. During the 232nd National Meeting of the Ame...
متن کاملCardiotoxicity of Anticancer Therapeutics
As cancer therapeutics continues to improve and progress, the adverse side effects associated with anticancer treatments have also attracted more attention and have become extensively explored. Consequently, the importance of posttreatment follow-ups is becoming increasingly relevant to the discussion. Contemporary treatment methods, such as tyrosine kinase inhibitors, anthracycline chemotherap...
متن کاملThe Relationship of Secretion and Activity of Recombinant Factor IX with N-Glycosylation
Background: Human coagulation factor IX (hFIX) is a glycoprotein with two N-glycosylation sites at the activation peptide. Since the activation peptide is removed in mature hFIX, the exact role of N-glycosylation is unclear. To investigate the role of N-glycosylation in the secretion and activity of hFIX, we inhibited N-glycosylation by tunicamycin in the stable Human Embryonic Kidney (HEK)- c...
متن کاملN-Glycosylation of Recombinant Therapeutic Glycoproteins in Plant Systems
Transgenic plants have recently emerged as a promising system for low-cost and large-scale production of therapeutic proteins. Despite many advantages plants offer as hosts for expression of recombinant proteins, there are certain limitations caused by major structural differences between plant and mammalian N-linked glycans. Thus, efforts are being made in order to eliminate, or at least minim...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Research
سال: 2018
ISSN: 0008-5472,1538-7445
DOI: 10.1158/0008-5472.can-18-0032